UNC Children's Research Institute

Chapel Hill, North Carolina 27599

2 studies enrolling now · 4 studies all time

What they study most

Mucopolysaccharidosis II

Studies at this site

• A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II) — Recruiting now
• An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007 — Enrolling by invitation
• A Study of Tividenofusp Alfa (DNL310) in Pediatric Participants With Hunter Syndrome — Running, not enrolling
• A Study of Potential Treatment-Responsive Biomarkers and Clinical Outcomes in Hunter Syndrome — Completed